Key Points

The Health Ministry is calling an urgent meeting with all state health officials after ten children died from toxic cough syrup. Laboratory tests revealed the Coldrif syrup contained nearly 50% diethylene glycol, a dangerous industrial solvent. A doctor has been arrested for prescribing the contaminated medication to young patients suffering from cough and fever. The government has now banned the syrup and issued warnings against using such medications for children under five.

Key Points: Health Ministry Meets on Toxic Cough Syrup Child Deaths

  • Health Ministry holds emergency meeting with all state health secretaries
  • Coldrif cough syrup contained 48.6% toxic industrial solvent
  • Ten children died from kidney failure after consuming contaminated syrup
  • Tamil Nadu-based Srisan Pharmaceuticals faces criminal case
  • Doctor arrested for prescribing the toxic cough syrup to patients
  • Government issues advisory against cough syrup use in young children
2 min read

Health Ministry to hold key meeting amid cough syrup row

Urgent meeting after 10 children die from contaminated Coldrif syrup containing toxic diethylene glycol. State health officials to discuss medicine quality control.

"The syrup contained 48.6 per cent diethylene glycol - Government Drug Analyst"

New Delhi, Oct 5

The Union Health Ministry will hold an important meeting on Sunday at 4 p.m. to discuss the children's deaths linked to 'toxic' cough syrup, according to sources.

The meeting will be led by the Secretary of the Health Ministry, with the Principal Secretaries and Health Secretaries from all states and union territories in attendance. Additionally, Drug Controllers from each state and union territory will also be present.

The meeting will be conducted via video conferencing to discuss the misuse of cough syrup and the quality of medicines, according to the sources.

Discussion on the rational and prudent use of cough syrups and measures to ensure the quality of medicines is also included in the meeting's agenda.

The government on Friday issued an advisory to all states and union territories, urging the rational use of such syrups in children. It said these are generally not recommended for children below five years, and above that, any use should follow careful clinical evaluation with close supervision.

This meeting on Sunday has been called in light of the seriousness of the recent cases of deaths related to cough syrups.

The tragedy unfolded after the youngsters, who initially showed signs of recovery, later developed severe complications that led to kidney failure and, ultimately, death.

Following the incident, the Madhya Pradesh government has registered a case against Srisan Pharmaceuticals, the Tamil Nadu-based company located in Kanchipuram that manufactures Coldrif.

Authorities confirmed that the syrup samples tested positive for dangerously high levels of diethylene glycol -- a highly toxic industrial solvent.

According to officials, laboratory analysis conducted by the government drug analyst at the Drug Testing Laboratory in Chennai revealed that the syrup contained 48.6 per cent diethylene glycol.

The Tamil Nadu Directorate of Drug Control subsequently declared the sample "Not of Standard Quality". The state government promptly imposed a ban on the sale and distribution of Coldrif across Madhya Pradesh.

Earlier in the day, police said that a doctor in Madhya Pradesh's Chhindwara district has been arrested after the deaths of 10 children linked to the consumption of adulterated Coldrif cough syrup triggered widespread outrage.

Most of the deceased children were treated at the private clinic of paediatrician Dr Praveen Soni in Parasia. Soni, who is also employed as a government doctor, reportedly prescribed the Coldrif syrup to several children suffering from cough and seasonal fever.

- IANS

Share this article:

Reader Comments

R
Rohit P
Finally some action being taken! But why does it always take children's deaths for the government to wake up? Our drug regulation system needs complete overhaul. 48.6% diethylene glycol - how did this even pass quality checks? 🤯
D
David E
As someone working in pharmaceutical quality control, I appreciate the government's quick response. Video conference with all states is the right approach. We need uniform drug testing standards across India to prevent such tragedies.
A
Ananya R
The doctor should also be held accountable. How can a pediatrician prescribe such medicines without proper verification? Parents trust doctors blindly in our country. This incident should make everyone more cautious about medication.
S
Sarah B
While I support strict action, let's not forget that most Indian pharmaceutical companies maintain high standards. One bad apple shouldn't destroy the reputation of our entire pharma industry which supplies affordable medicines globally.
V
Vikram M
Hope this meeting leads to concrete measures and not just another bureaucratic exercise. We need regular surprise inspections, stricter penalties, and better monitoring systems. Jai Hind! 🇮🇳

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50